Welcome to our dedicated page for VAULTZ CAP PLC news (Ticker: VZTCF), a resource for investors and traders seeking the latest updates and insights on VAULTZ CAP PLC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect VAULTZ CAP PLC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of VAULTZ CAP PLC's position in the market.
Vaultz Capital (OTCQB: VZTCF) commenced trading on the OTCQB Venture Market on October 24, 2025, following approval by OTC Market Group Inc.
The company's ordinary shares will continue to trade on the Aquis Stock Exchange and the Frankfurt Stock Exchange; no new ordinary shares will be issued for this cross-trade arrangement. Trading on OTCQB does not subject Vaultz to Sarbanes-Oxley or SEC reporting. US investors can view real-time quotes and company news on otcmarkets.com. Management said the move aims to broaden the global investor base, improve visibility and support long-term capital strategy.
